Mode
Text Size
Log in / Sign up
N/A N=100 Randomized Single-blind Supportive Care

Study of Carbon Dioxide Exchange Patterns During Robotic Prostatectomies

Prostate Cancer · Pneumoperitoneum

Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Nov 2021
Primary outcome: Primary: Intraoperative Pneumoperitoneal Pressure (mmHg) — 7.9; 9.9 mmHg — p=<0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
AirSeal System (Device); Standard Endopath (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
Male
Sponsor
OhioHealth
Primary completion
May 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Intraoperative Pneumoperitoneal Pressure (mmHg)
7.9; 9.9 <0.001 sig
SECONDARY
Intraoperative Arterial Blood Gas Carbon Dioxide (mmHg).
39.5; 39.2; 41.5; 41.2; 45.1; 44.1 0.39
SECONDARY
End-tidal Carbon Dioxide Pressure (mmHg)
31.47; 29.96; 32.80; 30.96; 34.77; 34.17 0.13
SECONDARY
Carbon Dioxide Elimination (mmHg)
3.15; 3.28; 3.24; 3.28; 3.04; 3.11 0.42
SECONDARY
Intraoperative Arterial Blood Gas Oxygen (mmHg).
361.9; 364.3; 283.9; 294; 286.5; 290.2 0.88
SECONDARY
Number of Ventilator Interventions
0.69; 0.66 0.41
SECONDARY
Procedure Time (Minutes)
158.6; 153.0 0.09
SECONDARY
Smoke Evacuation Quality
4; 16; 25; 18; 20; 14 <0.001 sig

Summary

The AirSeal® System will allow for lower carbon dioxide (CO2) absorption rates than the standard Endopath System.

Eligibility Criteria

Inclusion Criteria

  • Age>18
  • Eligible and elect to undergo robotic prostatectomy surgery @ OhioHealth Dublin Methodist Hospital

Exclusion Criteria

  • Age 44 or <18
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02114164). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search